Beretta's 25% in Sturm Ruger Isn't a Takeover — It's a Foreign Bid for the Last Independent US Firearms Shelf, Rewritten by the FTC

Beretta spent ~$54.8M to buy the seat at the table. On September 22, 2025, Beretta Holding (Luxembourg, parent of Beretta, Benelli, Sako, Tikka, Stoeger, Franchi, Burris) filed a Schedule 13D disclosing a 7.7% stake in Sturm Ruger — 1,454,900 shares, acquired without prior notice to management. By October 2, 2025 the position was 9.0%; by March 2026 it had crept to 9.95%, making Beretta Sturm Ruger's largest shareholder and triggering the October 14, 2025 poison pill that activates at any 10.0%+ holder.

Beretta's tender price is ~20% above today's quote. At the May 4, 2026 close of $37.23, Sturm Ruger trades roughly 17% below Beretta's $44.80 offer — implying the market is pricing in either no deal, a regulatory block, or a substantial haircut on the FTC-capped upside. Trailing P/E sits at 48.4x on TTM earnings of $0.73/share; EV/EBITDA is 20.3x on TTM EBITDA of $32.5M, despite net cash of $29.2M and zero long-term debt.

Two companies that compete in the same market cannot share a board. Section 8 of the Clayton Act, dating to 1914 and long dormant, prohibits interlocking directorates between \"horizontal competitors\" — firms that compete in the same line of commerce. With Beretta (Sako, Tikka, Benelli, Stoeger) and Sturm Ruger both selling bolt-action rifles, shotguns, and semiautomatic pistols into the US commercial sporting market, the FTC ruled on September 16, 2026 that any cross-board service would be presumptively illegal.

Ruger is the last publicly traded, family-influenced, US-based firearms manufacturer with a wholly owned factory footprint. Smith & Wesson Brands is a public company on the NASDAQ (swbi) — but its manufacturing is consolidated in Maryville, Tennessee and it has no lever-action heritage. Beretta's existing US brands (Sako, Tikka, Benelli, Stoeger) source primarily from Finland and Italy. Sturm Ruger is the lever Beretta pulls to get American-made capacity, a captive independent distributor network, and the revived Marlin lever-action franchise.

Marlin lever-actions are the prize. Marlin-branded rifles contributed $40.6M, or 33.7% of Q3 2025 firearm sales, and $173M for the full year 2025 — roughly 33% of total firearm revenue, per industry trackers citing Ruger disclosures. Beretta's Sako and Tikka bolt-action lines compete head-to-head with the Ruger American; the Marlin 1895 and Model 336 lever-actions fill a price-performance slot neither Sako nor Tikka addresses. A 25% stake and board observer rights give Beretta first-look economics on Marlin SKU mix without owning the IP outright.

Ruger paid for the Beretta fight out of operating cash flow. Full-year 2025 produced a net loss of $4.4M, despite revenue of $546.1M, after Q1 2026 absorbed $3.2M in agreement-related legal and advisory fees plus a $2.5M severance charge for a reduction-in-force. Q1 2026 GAAP diluted EPS collapsed to $0.01 (adjusted $0.27) on $141.4M revenue; Q2 2026 rebounded to $0.43 GAAP / $0.52 adjusted on $158.1M revenue, beating consensus $0.42 by ~24%.

New products are doing the work. Q1 2026 new-product sales hit $51.6M, 41% of firearm sales, led by Marlin lever-actions, the RXM pistol, and the American Centerfire Rifle Gen II. Management returned $1.3M in dividends in Q1 and authorized a $0.21 quarterly dividend for Q2 2026 — payable August 28, record August 14. With $117.5M of cash and short-term investments at quarter-end and no long-term debt, Ruger is funding the Beretta response from its own balance sheet rather than issuing equity at depressed prices.

The $44.80 tender is a put, not a catalyst. With Sturm Ruger trading at $37.23, the market is pricing meaningful execution risk on the tender (FTC, shareholder vote, court challenge) and discounting the cooperation-agreement optionality. Two things change that: an FTC final order that ratifies the deal without new conditions, and Beretta's tender actually launching and clearing. Until then, the bid is a backstop, not a thesis.

The thesis is \"Ruger is the only US-domiciled, US-manufactured, publicly traded firearms platform with strategic-asset scarcity value.\" That scarcity is what Beretta is paying for. Smith & Wesson — at $13.06 with a $584M market cap, ~9.5x EV/EBITDA on 12% EBITDA margins — is the comparison point for non-strategic firearms peers. Ruger's 18.7% gross margin and 4.8% EBITDA margin are below Smith & Wesson's 27.4% and 12.1% respectively; the strategic premium can persist only if the Beretta deal closes cleanly and the cooperation framework generates sourcing or distribution synergies.

For the rest of the firearms shelf, the read-through is hostile. Smith & Wesson is the next-largest US-listed pure-play. If a foreign strategic (Beretta, a Korean/Chinese optics group, a private-equity-backed Italian roll-up) decides 25% is the new floor, swbi at $584M with a 3.6x current ratio and 95% dividend payout is the most plausible target. The Marlin franchise alone is the kind of SKU set that warrants a strategic premium, and only Sturm Ruger and Smith & Wesson can deliver it inside a US-listed shell.